Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — insulin resistance

A comprehensive guide to understanding hormone health—from adrenal function and thyroid balance to menopause, andropause, metabolism, and reproductive wellness. Learn how hormonal imbalances develop, how they affect energy, mood, weight, and overall wellbeing, and how modern testing methods like saliva, blood spot, and bioidentical therapies can support personalised health and long-term vitality.

Cardiometabolic risk is a cluster of conditions — including high insulin, cholesterol, and blood sugar — that significantly raise the risk of heart disease and diabetes. Early testing is key to prevention.

The rise in cardiovascular disease (CVD), obesity, and type 2 diabetes (DM2) is one of the most pressing health concerns of our time. CVD remains the leading cause of death for both men and women in the United States. Alarmingly, obesity and insulin resistance—precursors to DM2—significantly increase the risk of developing CVD. Yet, these conditions are largely preventable with early detection and lifestyle changes. So, how can we spot the danger before it's too late? What is CardioMetabolic Risk? Cardiometabolic risk refers to a cluster of modifiable risk factors and biological markers that signal an increased likelihood of developing CVD and...

The UK is facing a growing obesity crisis, with two-thirds of adults and a rising number of children classified as overweight or obese. A recent UK Parliament briefing highlights alarming trends, including regional and ethnic disparities and increased risks linked to socioeconomic status. While public health strategies continue to evolve, addressing the hormonal root of weight gain may offer a more effective, personalized solution. ZRT Laboratory’s Weight Management Profile helps uncover hidden hormonal imbalances—such as elevated cortisol, low testosterone, or thyroid dysfunction—that contribute to stubborn fat gain, poor metabolism, and increased disease risk.

By Dr.Tracy Tranchitella, ND-ZRT Laboratory Non-Alcoholic Fatty Liver Disease (NAFLD) has become a primary cause of chronic liver disease, impacting a large portion of the global population. NAFLD is characterized by the buildup of excess fat in the liver, unrelated to alcohol use, and is strongly associated with metabolic syndrome—a group of conditions that raise the risk of heart disease, stroke, and diabetes. Factors contributing to metabolic syndrome may also play a role in the development of NAFLD, but underlying endocrine disorders can further drive the onset and progression of this widespread liver condition. Moreover, environmental and chemical toxins may...